Non-vascular stents are medical devices used to maintain patency in non-vascular bodily conduits, addressing conditions like lung cancer (2.38 million new cases annually), COPD (300 million cases), and gastrointestinal or urological disorders. The market is driven by rising chronic disease prevalence, an aging population (2.1 billion over 60 by 2050), and a shift toward minimally invasive techniques that reduce hospital stays. Innovations such as biodegradable stents and advanced materials like nitinol enhance efficacy. The global market is projected to reach between USD 910 million and USD 1.50 billion in 2025, with a CAGR of 3.2% to 5.4% through 2030.
This product will be delivered within 1-3 business days.
Regional Analysis
- North America: The U.S. leads with high chronic disease rates, while Canada focuses on elderly care.
- Europe: Germany, France, and the UK drive demand due to advanced healthcare and aging populations.
- Asia Pacific: China and India see growth from rising disease burden, while Japan emphasizes precision treatments.
- Rest of the World: Brazil expands stenting procedures, and the Middle East invests in medical advancements.
Application Analysis
- Hospitals: Expected growth of 3.0%-5.2%, driven by complex cases. Trends focus on durable stents.
- Ambulatory Care Centers (ASCs): Projected growth of 3.4%-5.6%, linked to outpatient procedures. Developments emphasize quick deployment.
- Specialty Clinics: Anticipated growth of 3.2%-5.4%, suited for targeted treatments. Advances prioritize patient comfort.
Type Analysis
- Gastrointestinal Stents: Expected growth of 3.3%-5.5%, valued for digestive relief. Trends highlight biodegradability.
- Urological Stents: Projected growth of 3.1%-5.3%, key for urinary flow. Advances focus on comfort.
- Pulmonary (Airway) Stents: Anticipated growth of 3.5%-5.7%, driven by lung conditions. Innovations emphasize airway support.
- Biliary Stents: Expected growth of 3.0%-5.2%, suited for bile duct issues. Trends lean toward durability.
- Others: Projected growth of 2.9%-5.1%, covering niche uses. Advances focus on customization.
Key Market Players
Leading firms include Boston Scientific Corporation, offering airway stents; Medtronic, enhancing stent designs; TAEWOONG, specializing in GI stents; Cook Medical, advancing iCast; CONMED Corporation, supporting endoscopy; Micro-Tech (Nanjing), focusing on digestive stents; ELLA-CS, s.r.o., innovating with biodegradable options; and Merit Medical, targeting non-vascular solutions.Porter's Five Forces Analysis
- Threat of New Entrants: Moderate, due to regulatory and manufacturing barriers, though innovative startups can emerge.
- Threat of Substitutes: Low, as non-vascular stents are essential for specific conditions with no direct alternatives.
- Bargaining Power of Buyers: Moderate, with facilities seeking effective, affordable stents, though specialized needs limit options.
- Bargaining Power of Suppliers: Low, with multiple material suppliers.
- Competitive Rivalry: High, with competition on biodegradability, material innovation, and procedure efficiency.
Market Opportunities and Challenges
Opportunities
- Lung cancer (2.38 million cases) and COPD (300 million cases) drive demand.
- Aging populations (2.1 billion over 60 by 2050) and injury-related needs boost growth, while biodegradable stents and AI navigation enhance outcomes.
- Minimally invasive preferences increase adoption.
Challenges
- High costs of advanced stents limit penetration in low-income regions.
- Regulatory delays for new materials slow entry.
- Limited specialists in rural areas restrict market reach.
Market News:
- In January 2024, Olympus Corporation acquired Taewoong Medical Co., Ltd., strengthening its GI stent portfolio.
- In March 2024, Cook Medical and Getinge signed a distribution contract for the iCast covered stent system in the U.S.
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
Chapter 4 Market Landscape
Chapter 5 Market Trend Analysis
Chapter 6 Industry Chain Analysis
Chapter 7 Latest Market Dynamics
Chapter 8 Historical and Forecast Non-Vascular Stent Market in North America (2020-2030)
Chapter 9 Historical and Forecast Non-Vascular Stent Market in South America (2020-2030)
Chapter 10 Historical and Forecast Non-Vascular Stent Market in Asia & Pacific (2020-2030)
Chapter 11 Historical and Forecast Non-Vascular Stent Market in Europe (2020-2030)
Chapter 12 Historical and Forecast Non-Vascular Stent Market in MEA (2020-2030)
Chapter 13 Summary For Global Non-Vascular Stent Market (2020-2025)
Chapter 14 Global Non-Vascular Stent Market Forecast (2025-2030)
Chapter 15 Analysis of Global Key Vendors
List of Tables and Figures
Companies Mentioned
- Boston Scientific Corporation
- Medtronic
- TAEWOONG
- Cook Medical
- CONMED Corporation
- Micro-Tech (Nanjing)
- ELLA-CS
- s.r.o.
- M
- erit Medical